MX2019007595A - Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri. - Google Patents

Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri.

Info

Publication number
MX2019007595A
MX2019007595A MX2019007595A MX2019007595A MX2019007595A MX 2019007595 A MX2019007595 A MX 2019007595A MX 2019007595 A MX2019007595 A MX 2019007595A MX 2019007595 A MX2019007595 A MX 2019007595A MX 2019007595 A MX2019007595 A MX 2019007595A
Authority
MX
Mexico
Prior art keywords
tetraazabicyclo
imaging agents
compounds suitable
chelate compounds
mri imaging
Prior art date
Application number
MX2019007595A
Other languages
English (en)
Inventor
Christopher Bales Brian
James Rishel Michael
Richard Meijer Andreas
Jacob THANING Mikkel
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of MX2019007595A publication Critical patent/MX2019007595A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención proporciona compuestos de la fórmula (I) que representa un poli-aza-macrociclo con brazos laterales de ácido carboxílico que forman complejo con manganeso como el metal del núcleo. Los complejos son adecuados para usarse como agentes de contraste en la toma de imágenes de resonancia magnética (MRI).
MX2019007595A 2016-12-21 2017-12-21 Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri. MX2019007595A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662437082P 2016-12-21 2016-12-21
PCT/EP2017/084148 WO2018115314A1 (en) 2016-12-21 2017-12-21 Tetraazabicyclo-macrocycle based manganese chelate compounds suitable as mri imaging agents

Publications (1)

Publication Number Publication Date
MX2019007595A true MX2019007595A (es) 2019-09-09

Family

ID=60857088

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019007595A MX2019007595A (es) 2016-12-21 2017-12-21 Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri.

Country Status (17)

Country Link
US (1) US10730897B2 (es)
EP (1) EP3558394B1 (es)
JP (1) JP7258753B2 (es)
KR (1) KR102550339B1 (es)
CN (1) CN110290815A (es)
AU (1) AU2017382953B2 (es)
BR (1) BR112019012757A2 (es)
CA (1) CA3048104A1 (es)
DK (1) DK3558394T3 (es)
ES (1) ES2813077T3 (es)
HU (1) HUE050402T2 (es)
LT (1) LT3558394T (es)
MX (1) MX2019007595A (es)
PL (1) PL3558394T3 (es)
RU (1) RU2769699C2 (es)
WO (1) WO2018115314A1 (es)
ZA (1) ZA201904006B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
EP3728168B1 (en) 2017-12-20 2022-03-30 General Electric Company Anionic chelate compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU608759B2 (en) 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
NZ230778A (en) 1988-09-27 1993-01-27 Salutar Inc Diagnostic imaging contrast medium comprising biscarbamoyl derivatives
HUT66220A (en) * 1991-12-10 1994-10-28 Dow Chemical Co Bicyclopolyazamacrocyclophosponic acids, their complexes and conjugates for use as contrast agents, and processes for their preparation
FR2794744B1 (fr) * 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
WO2006002873A2 (en) 2004-07-02 2006-01-12 Bracco Imaging Spa 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri )
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
NO331773B1 (no) * 2009-12-18 2012-03-26 Ge Healthcare As Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
WO2014174120A1 (fr) * 2013-04-26 2014-10-30 Guerbet Formulation de produit de contraste et son procede de preparation associe
GB201610738D0 (en) * 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds

Also Published As

Publication number Publication date
KR102550339B1 (ko) 2023-07-04
LT3558394T (lt) 2020-09-10
ES2813077T3 (es) 2021-03-22
US20200062791A1 (en) 2020-02-27
BR112019012757A2 (pt) 2019-11-26
PL3558394T3 (pl) 2020-11-16
JP2020503310A (ja) 2020-01-30
US10730897B2 (en) 2020-08-04
HUE050402T2 (hu) 2020-12-28
RU2019118365A3 (es) 2021-03-09
JP7258753B2 (ja) 2023-04-17
AU2017382953A1 (en) 2019-07-04
DK3558394T3 (da) 2020-08-24
RU2019118365A (ru) 2021-01-22
ZA201904006B (en) 2022-04-28
AU2017382953A2 (en) 2019-09-12
WO2018115314A1 (en) 2018-06-28
EP3558394A1 (en) 2019-10-30
RU2769699C2 (ru) 2022-04-05
CA3048104A1 (en) 2018-06-28
EP3558394B1 (en) 2020-06-03
CN110290815A (zh) 2019-09-27
AU2017382953B2 (en) 2021-10-21
KR20190098193A (ko) 2019-08-21

Similar Documents

Publication Publication Date Title
PH12017502205A1 (en) New gadolinium chelate compounds for use in magnetic resonance imaging
MX2018007043A (es) Agentes de contraste dimericos.
MX2018016082A (es) Compuestos quelatos.
BR112018011541A2 (pt) agentes de contraste
EP2981293A4 (en) Metal oxide nanoparticle-based magnetic resonance imaging contrast agent with a central cavity
SG11201600956QA (en) Coil assembly for magnetic resonance imaging
WO2014037498A3 (en) Paramagnetic solid lipid nanoparticles (pslns) containing metal amphiphilic complexes for mri.
MX2019007595A (es) Compuestos de quelato de manganeso basados en tetra-azabiciclo-macrociclos adecuados como agentes de toma de imagenes mri.
IN2015DN00209A (es)
IL271622A (en) A nanoparticle, a magnetic resonance imaging contrast agent containing it, and a ligand
MX2022002586A (es) Isomeros de quelatos de manganeso.
ZA202103859B (en) Metal oxides nanoparticles conjugated with naphthalene derivatives as contrast agents for the detection of beta amyloid plaques by magnetic resonance images
GB201717753D0 (en) Shimming coils for magnetic resonance imaging
EP4045095C0 (de) Eisen(iii)-komplexe mit neuen kontrastmitteleigenschaften für die magnetresonanztomographie
RU2012125493A (ru) Металлокомплексы тетра-(4-трет-бутил-5-нитро)фталоцианина
HUE050765T2 (hu) Etilén-diamin-tetraecetsav-bisz(amid) származékok és Mn(II) ionokkal képzett vonatkozó komplexeik MRI kontrasztanyagként történõ alkalmazásra
NZ703409A (en) Use of an amphoteric chelating agent for preventing contact allergies
GB2599535B (en) Novel magnetic resonance imaging contrast agents
HK1205465A1 (en) Bis azainositol heavy metal complexes for -ray imaging
EP3674444C0 (en) ELECTROCHEMICAL PROCESS FOR PRODUCING MAGNETIC IRON OXIDE NANOPARTICLES
UA86024U (ru) Бис[n-(салицил-2-фурил-2-морфолилэтил)]альдиминат меди как присадка для ингибирования окисления бензилового спирта